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Abstract  
Introduction: precancerous cervical lesion is significantly a health problem globally. Thus, screening targeting women between the ages of 17-60 
is being undertaken in developing countries, including Cameroon. Over 50% (7.8 per 100,000) women die of cervical cancer every year. This study 
was to determine the prevalence of precancerous cervical lesion, the age demography and access the risk factor. Methods: a hospital-based cross-
sectional study was conducted from August 09th to October 17th 2017. A total of 60 women participated, and were screened for precancerous 
cervical lesion. Data were collected by using a questionnaire. Visual inspection with acetic acid and visual inspection with Lugol’s iodine was applied 
for the screening. SPSS version 16.0 was used for data entry and analysis. Logistic regression analysis was fitted and odds ratios with 95% confidence 
intervals and p-values were computed to identify factors associated with precancerous cervical cancer lesion. Results: out of 60 study participants, 
2(3.33%) were found to be positive for precancerous cervical cancer lesion. Conclusion: the prevalence of precancerous cervical lesion in women 
that consulted at the Mezam polyclinic is high. 
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Women in Africa as well as those residing in Cameroon, suffer a 
disproportionate rate of cervical cancer morbidity and mortality [1]. 
Cervical cancer is the second leading cause of cancer-related deaths 
amongst Cameroonian women in West Africa. Human papillomavirus 
(HPV) leads to cervical cancer. Particularly, the strains HPV 16 and 18 
have been especially known to be at high risk [2]. In Cameroon, 
cervical cancer screening services and testing for HPV are mostly 
available at private health clinics and some government hospitals in 
the urban areas. In Cameroon most cases of cervical cancer are 
diagnosed at later and more serious stages. Majority of the cervical 
cancer victims are poor rural women who are particularly unable to 
access screening and testing services [2, 3]. Those who screen are 
unable to return for follow-up or complete treatment due to: 
inadequate medical advice, lack of awareness of the significance of 
their symptoms, cultural and religious factors as well as the lack of 
finances to pay for the services. 
  
The cancer of the cervix is at the origin of 3 387 new cases and of 
1000 deaths per annum corresponding to an average incidence of 8 
per 100 000 person-years in 2000. It is located at the 2nd rank of 
female cancers in term of incidence and there thus remains a priority 
to public health [4]. In Cameroon one estimates that approximately 
1400 to 1700 new cases of cancer of the cervix per annum and 
approximately 700 of them die each year [5]. The cancer of the cervix 
is preceded during 10 to 15 years by precancerous lesions. Those are 
detectable by the smear and their treatment makes it possible to 
avoid or reduce the risk of evolution towards an invasive cancer [6]. 
The screening of the cancer of the cervix in Europe (France) is 
individual but there are recommendations for clinical practice where 
it is advised to carry out a smear every 3 years after 2 normal annual 
smears for women from 25 to 65 years [7]. 
  
A precancerous state of the cervix is characterized by changes 
undergone by the cells of the collar which make them more likely to 
evolve in a cancer. This state is not yet a cancer, but it is strongly 
likely to be transformed into cancer of the cervix in 10 years or more 
if it is not treated in time [8]. One finds a cervical dysplasia at 1 to 
5% of the women in the general population. They concern primarily 
the young, old women from 25 to 35 years [9]. It is estimated that 
each year, appear approximately 69 000 new cases of dysplasia of 
low rank and 15 000 cases of dysplasia of high rank in Europe [10]. 
The papillomavirus (human papillomavirus: HPV) are known and are 
very many, they are responsible for a multitude of lesions found on 
the skin or the mucous membranes [11]. By infecting the cells of the 
cervix, they lead to lesions which at term can evolve to a cancer. The 
co-infection by viruses AIDS and HPV is at the origin of a growing 
number of cancers for seropositive people. A new study on nearly a 
half-million patients shows it with force [12]. 
  
Five main types of cancer that affect a woman's reproductive organs 
are known as gynecologic cancer: cervical, ovarian, uterine, vaginal, 
and vulvar (Centers for Disease Control and Prevention) [13]. 
According to [14], of the 83,745 women diagnosed with gynecologic 
cancer in the United States died from the disease. CDC further stated 
that cervical cancer used to be the leading cause of cancer death for 
women in the United States. However, in the past 40 years, the 
number of cases of cervical cancer and the number of deaths from 
cervical cancer have decreased significantly because of the availability 
of regular Pap tests, which can locate cervical precancerous lesions 
before they turn into cancer. Mqoqi N et al. and Bailie RS et al. 
[14, 15] said cervical cancer can be prevented using: the HPV 
vaccines, the Pap test (or Pap smear) looking for pre-cancers, and 
also using Visual inspection with acetic acid (VIA), Visual inspection 
with Lugol’s iodine (VILI), the HPV test that looks for viruses that can 
cause cellular changes. Regular screening beginning at the age of 17 
is the most important preventive measure. Other preventive 
measures include: the use of condoms during sexual contacts, limiting 
the number of sexual partners and avoid smoking [15]. 
  
Atypical squamous cells: if the doctor tells a woman that she has 
atypical squamous cells, it means that abnormalities has been 
detected in the squamous cells of her cervix. This can indicate that 
she has a human papillomavirus (HPV) infection, another infection, or 
possibly precancerous cells of another cause. The doctor may 
recommend further testing to determine what the abnormalities are. 
In some cases, this may simply mean a repeat Pap test in a few 
months. A test with this kind of finding may be reported as “atypical 
squamous cells of uncertain significance,” abbreviated as ASCUS 
(Figure 1). 
  
Squamous intraepithelial lesion (SIL): this lesion means that 
you have changes on your cervix that may be precancerous. SIL 
lesions are classified as either low-grade (LSIL) or high-grade (HSIL), 
with high-grade lesions being more likely to progress to cervical 
cancer (Figure 2). Transformation zone (TZ) is the name given to 
the area of the cervix comprising epithelium that has undergone 
squamous metaplastic change. It is the area of squamous metaplasia 
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between the squamocolumnar junction and the ectocervix. It is 
characterized by immature squamous epithelium beneath which 
endocervical crypts may be seen on histology. This area is where most 
abnormalities are thought to arise (Figure 3, Figure 4). Three vaccines 
Gardasil, Gardasil-9, and Cervarix have been approved by the food 
and drug administration (FDA) to help prevent infection with some 
types of HPV, including the types that cause most cases of cervical 
cancer. Gynecologists suggest that, boys and girls both should be 
vaccinated between ages 11 and 12 before they become sexually 
active; those between ages 13 and 26 who have not yet received the 





Study area, design and population 
  
The study was carried out at Mezam polyclinic since they have the 
necessary facilities and the women who come are sure to be tested 
for and treated if need be. The study was a hospital based cross-





The sample size was calculated based on the LORENTZ formula 
  
Calculated sample size r n = t × t × p (1 - p)/ m × n 
  
When n = required sample size; t = confidence level at 95% 
(standard value 1.96); m = margin of error 5% (standard value of 
0.05); p = prevalence estimated of a condition under investigation in 
the project (3.9% of women where tested positive for precancerous 
cervical lesions (39). 
  
t = 1.96, m = 0.05, p = 3.9 %( 0.1) 
  
n = 1.96 × 1.96 × 0.039(1-0.039)/0.05×0.05 
  
n = 3.8426 × 0.037/0.0025 
  
n = 3.8416 × 14.8 
  
n = 56.9. 
Sampling: a total of 60 (due to time constrains) women were 




Inclusive criteria: only sexual active women of ages 17-60 will 
participate in the study. This is because this infection occurs most 
often in women within this age group. 
  
Exclusive criteria: non-sexual active women within the said age 
range shall not take part in the study. This is because there is a lesser 
chance for non-sexual active women to come down with 
precancerous cervical lesions. Women who did not sign the consent 
form were excluded from the research work. 
  
Materials: examination table, adequate light source, sterile vaginal 
speculum, new examination gloves, large cotton swabs, dilute (3-5%) 
acetic acid (vinegar) and a small bowl, lugol’s iodine solution and a 




Visual inspection with 5% acetic acid (VIA) 
  
The woman is asked to lie in a gynecological position, and the external 
genitalia os examined with the help of a good light source. A speculum 
is used to help open the vagina and expose the external os of the 
cervix. A large cotton swab is deep in the bowl containing 5% acetic 
acid is applied to the external os. After a minute, view the cervix with 
the naked eyes to identify color changes on the cervix. To determine 
whether the test result is positive (Abnormal tissue temporarily 
appears white when exposed to acetic acid) or negative (no color 
change) for possible precancerous lesions or cancer (Figure 5). If the 
result is positive a confirmatory test is done using Lugol’s iodine. A 
large cotton swab is deep in a bowl containing Lugol’s iodine and it’s 
applied to the cervix. After a minute, visually observe the cervix for 
positive (mustard-yellow coloration) or negative (brown coloration) 
(Figure 6, Figure 7). Demographic and clinical data were collected 
using questionnaire and information from the participants were 
presented on tables. Data was analysed using Microsoft excel (2010) 
by calculating the prevalence. A record book was used to record all 
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Out of the 60 participants, two were screened positive for 
precancerous cervical lesion, and 58 were screened negative. The age 
range was 17-60 years with a mean age of 38.5 years. 
  
Demographic distribution of participants 
  
Marital status: of the 60 women who participated in the study, 18 
(30.00%) were singles, 29 (48.33%) were married, 5 (8.33%) were 
divorce and 8 (13.33%) were widows (Table 1). 
  
Age distribution: out of the 60 women who enrolled, 17(28.33%) 
were between the age group 17-26 years, 17(28.33%) between the 
age groups 27-36 years, 18(30%) between 37-46 years, 6(10%) 
between 47-56 years, and 4 (3.33%) between 57-60 years (Table 1). 
  
Evaluation of risk factors: of the 60 participants, two were 
screened positive within the age group of 31-45 years of age. And 
there were fell in the group with more than two life partners, more 
than 3 children, early full term pregnancy between the ages 17-20 
years. One of them had a family history of cervical cancer (Table 2). 
  
Prevalence of precancerous cervical lesion in women: out of 
the 60 women who enrolled, 2(3.33%) where screened positive for 






The prevalence of precancerous lesion of the uterine cervix in 
Cameroon is similar to that reported in 1992 (4.2%) [16]. However, 
data from other countries reported a higher prevalence rate such as 
16.4% women in Central African Republic Africa. In the present study, 
patients were not tested for HIV. In developed countries as France, 
the prevalence of precancerous cervical lesion rate is much lower at 
around of 0.5%. The difference of prevalence of the precancerous 
lesions of the uterine cervix from one country to another is mainly 
due to the existence and consistency of screening programs and 
management options implemented in these countries. Higher 
prevalence of precancerous cervical lesions in women shown by this 
study has been reported in South Africa (66.3%), Uganda (73%), and 
Zambia (76%) [17]. Studies done in Kenya and Rwanda also found 
the prevalence of precancerous cervical cancer to be 26.7% and 
24.3% respectively, which are very high as comparable to the result 
of the current study. A lower prevalence of precancerous cervical 
cancer than the current study has also been reported from studies 
done in Botswana, Côte d'Ivoire, and Nigeria. In Botswana, a cervical 
cancer screening program of 2,175 women based on VIA found that 
the proportion of precancerous cervical cancer lesion confirmed by 
histology was 15.2% [18]. Studies recently conducted in Côte d'Ivoire 
and Nigeria found the prevalence of precancerous cervical cancer 
lesion to be 11% and 6% respectively [19]. Cervical cancer is the 
most common cancer in women in Africa and second to breast cancer. 
In Africa, it accounts for 22.2% of all cancers in women and it is also 
the most common cause of cancer-related death among women [20]. 
Knowing the prevalence and associated factors of precancerous 
cervical cancer lesion in women helps to take preventive measures 
and to know the screening requirements. In this study the prevalence 
of precancerous cervical cancer lesion in women was found to be 
3.33% which is comparable with a previous report of Cameroon 
women resident in Maryland (3.9%) [21]. The high prevalence of 
precancerous cervical cancer lesion reveals that cervical cancer is a 
significant public health problem in women. Despite the high 
prevalence of the lesion, only four hospitals in the northwest of 
Cameroon were providing screening and treatment service, which 
significantly hampered the service accessibility to all women in the 
region. This could be because of the limited resources available for 
treatment of positive precancerous cervical cancer lesion after 
screening with VIA and VILI as the current limited available services 
are donor dependent [22]. 
  
The differences among findings of prevalence of precancerous 
cervical lesion in different regions of Africa could be partly due to 
differences in the sexual practices of the women studied [23]. Having 
multiple sexual partners because of cultural differences increases the 
risk of acquiring HPV, and in turn, the development of cervical pre-
cancer and cancer. In Nigeria, with a low prevalence was reported, 
96% of the study participants had two or less lifetime sexual partners. 
 
Page number not for citation purposes     5 
 
In South Africa, one of the highest reported, the median number of 
sexual partners was four [24]. In the present study the mean number 
of lifetime sexual partner is 3 and might be one of the contributing 
factors for the high prevalence. Unlike the findings from South Africa 
and Nigeria [25], though 56% of women had an average of five 
lifetime sexual partners, prevalence was lower than the finding in the 
present study, making the association unlikely. It could also be a 
result of the limitation of self-reported sexual practices. The other 
possible explanation for the different prevalences could be the 
differences in the study populations. The age ranged from 17 to 60 
years with a mean age of 38.50 years and 85% of women were 
between the ages of 17-46 years. The mean number of deliveries for 
women with precancerous lesions of the uterine cervix was three 
childbirths and those with more than 3 deliveries represented 50%. 
Multiparity in women with precancerous cervical lesion was previously 
seen in Burkina Faso, West Africa [26]. These data lead to suggest 
the possibility of an association between multiple childbirths and 





Much of the precancerous cervical lesion problem can be solved with 
existing or soon-to-be available technology, sufficient will, and 
modest resources. Early detection, screening, and treatment of 
precancerous cervical lesion as well as HPV will reduce the rate of 
cancer. Implementation of cervical cancer screening in all eligible 
Cameroon women should be a national priority. The prevalence of 
cervical lesion infection (3.33%) is high at the Mezam polyclinic 
Bamenda. The prevalence of women who are at risk of precancerous 
cervical lesion is within the age group of 31-45 years. The risk factors 
that play a role at mediating the disease are: age, more than one 
lifetime sexual partner, having more than three children as well as 
early full term pregnancy between the age of 17-20. 
  
What is known about this topic 
 Prevalence of precancerous lesions of the uterine cervix in 
Cameroon; 
 Interactive model of client health behavior and cervical 
cancer screening of African-American women; 
 Knowledge and awareness about cervical cancer, and its 
prevention among interns and nursing staff in tertiary care 
hospitals. 
What this study adds 
 The need to create awareness on the disease by sensitizing 
the population and screening for the disease and screening 
for the disease should be added as one of the screening 
test done during booking at antenatal; 
 More health personnel’s should be trained so that they can 
make available the use of VIA and VILI test for screening 
in the district hospitals; 
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Table 1: distribution of participants based on marital status and age 







Single 18 30.00 
Married 29 48.33 
Divorce 5 8.33 
Widows 8 13.33 
Total 60 100 






17-26 17 28.33 
27-36 17 28.33 
37-46 18 30.00 
47-56 6 10.00 
57-60 2 3.33 
Total 60 100 
 
 




  Frequency Percentage Frequency Percentage 
Age         
17-30 24 40.00     
31-45 24 40.00 2 3.33 
46> 11 18.33 0 0 
Life sexual 
partners 
        
1 13 21.67 0 0 
2> 45 75.00 2 3.33 
Parity         
0-2 28 46.67 0 0 
3> 30 50.00 2 3.33 
Full term 
pregnancy 
        
17-20 28 46.67 2 3.33 
21> 30 50.00 0 0 
Family 
history 
        
Yes 2 3.33 1 1.67 
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Figure 2: precancerous cervical cancer infection of the cervix  
 
 
Figure 3: normal cells of the cervix  
 








Figure 5: A) an acetowhite area is not significant; B) acetowhite area is significant  
 





Figure 6: A) the squamous epithelium turns brown and columnar; B) there are scattered and uptake areas associated with immature no iodine 




Figure 7: A) well-defined, bright yellow iodine non uptake areas touching the squamo-columnar junction (SCJ); B) well-defined, bright 
yellow iodine non uptake areas close to uptake areas touching the squamo-columnar junction (SCJ) 
 
